Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Pedersen

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Danish Medical Bulletin|June 1, 1988
The human pharmacology of platelet inhibitory drugsA K Pedersen
Journal of Chromatography|January 1, 1979
Specific determination of dipyridamole in serum by high-performance liquid chromatographyA K Pedersen
Thrombosis Research|January 1, 1979
Two new metabolites of sulfinpyrazone in the rabbit: a possible cause of the prolonged in vivo effectA K Pedersen, P Jakobsen
The Journal of Pharmacy and Pharmacology|February 1, 1981
Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometryP Jakobsen, A K Pedersen
British Journal of Clinical Pharmacology|June 1, 1981
Sulphinpyrazone metabolism during long-term therapyA K Pedersen, P Jakobsen
The Journal of Bone and Joint Surgery. American Volume|January 1, 1988
Spondylolysis and spondylolisthesis. Treatment by internal fixation and bone-grafting of the defectA K Pedersen, R Hagen
Journal of Chromatography|July 21, 1979
Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detectionP Jakobsen, A K Pedersen
Journal of Chromatography|May 8, 1981
Simultaneous determination of sulfinpyrazone and four of its metabolites by high-performance liquid chromatographyP Jakobsen, A K Pedersen
Journal of Spinal Disorders|August 1, 1994
Complete fracture-dislocation of the atlantoaxial complex: case report and recommendations for a new classification of dens fracturesA K Pedersen, J P Kostuik
Clinical Pharmacology and Therapeutics|January 1, 1985
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosingA K Pedersen, G A FitzGerald
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Danish Medical Bulletin|June 1, 1988
The human pharmacology of platelet inhibitory drugsA K Pedersen
Journal of Chromatography|January 1, 1979
Specific determination of dipyridamole in serum by high-performance liquid chromatographyA K Pedersen
Thrombosis Research|January 1, 1979
Two new metabolites of sulfinpyrazone in the rabbit: a possible cause of the prolonged in vivo effectA K Pedersen, P Jakobsen
The Journal of Pharmacy and Pharmacology|February 1, 1981
Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometryP Jakobsen, A K Pedersen
British Journal of Clinical Pharmacology|June 1, 1981
Sulphinpyrazone metabolism during long-term therapyA K Pedersen, P Jakobsen
The Journal of Bone and Joint Surgery. American Volume|January 1, 1988
Spondylolysis and spondylolisthesis. Treatment by internal fixation and bone-grafting of the defectA K Pedersen, R Hagen
Journal of Chromatography|July 21, 1979
Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detectionP Jakobsen, A K Pedersen
Journal of Chromatography|May 8, 1981
Simultaneous determination of sulfinpyrazone and four of its metabolites by high-performance liquid chromatographyP Jakobsen, A K Pedersen
Journal of Spinal Disorders|August 1, 1994
Complete fracture-dislocation of the atlantoaxial complex: case report and recommendations for a new classification of dens fracturesA K Pedersen, J P Kostuik
Clinical Pharmacology and Therapeutics|January 1, 1985
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosingA K Pedersen, G A FitzGerald
Pageof 8